Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.
Diabetes mellitus is associated with vascular and neurological complications. We have investigated the presence of antibodies to phospholipids and to phospholipid binding plasma proteins in blood samples collected from 68 clinically and biochemically characterized type I and type II diabetic patients and from 252 healthy blood donor controls. Each sample was analysed for antibodies to three phospholipids (cardiolipin, phosphatidylserine and phosphatidylethanolamine), the antibody isotypes (IgA, IgG and IgM), and whether antibody activity was plasma protein-dependent. Patients were considered to have anti-phospholipid antibodies when one or more of these 18 tests was found above predetermined control values. The results of these experiments revealed an increased incidence of anti-phospholipid antibodies in diabetic patients compared with control subjects. The incidence of IgA isotype to phosphatidylethanolamine was higher than the incidence of other isotypes to other phospholipids, and their reactivities were independent of phospholipid-associated proteins. In addition, these antibody findings were studied for associations with prothrombin degradation products, activated factor VII and activated protein C, and with the incidence of diabetic complications. The anti-phosphatidylethanolamine antibody association with proliferative retinopathy was significant.
Gargiulo
P
P
Endocrinology, Clinica Medica 2, University 'La Sapienza' of Rome, Italy. gargiulo.p@tiscalinet.it
Goldberg
J
J
Romani
B
B
Schiaffini
R
R
Ciampalini
P
P
Faulk
W P
WP
McIntyre
J A
JA
D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D000918:Antibody Specificity; D002308:Cardiolipins / Q000276:immunology / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000276:immunology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000276:immunology*; D003930:Diabetic Retinopathy / Q000097:blood / Q000150:complications / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D015942:Factor VIIa / Q000378:metabolism; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood / Q000378:metabolism; D007074:Immunoglobulin G / Q000097:blood / Q000378:metabolism; D007075:Immunoglobulin M / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000276:immunology; D010714:Phosphatidylethanolamines / Q000276:immunology / Q000378:metabolism; D010718:Phosphatidylserines / Q000276:immunology / Q000378:metabolism; D011486:Protein C / Q000378:metabolism; D012680:Sensitivity and Specificity
D017152:Antibodies, Antiphospholipid; D002308:Cardiolipins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010714:Phosphatidylethanolamines; D010718:Phosphatidylserines; D011486:Protein C; D015942:Factor VIIa